Ritonavir

Common brands: Norvir, Ritonavir Film Coated, Prezista, Reyataz, Truvada

Top reporter: Abbvie Inc.

Cytochrome P450 3A Inhibitor [EPC]Protease Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
28,964
Total Reports
6,825
Serious Reports
2,620
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.05%)

Patient Demographics

Male
15,132
Female
8,975

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ritonavir.

# Reaction Reports % of Total
1 DRUG INTERACTION 2,548
8.4%
2 FOETAL EXPOSURE DURING PREGNANCY 2,375
7.8%
3 ANXIETY 1,622
5.3%
4 PAIN 1,573
5.2%
5 EMOTIONAL DISTRESS 1,388
4.6%
6 ANHEDONIA 1,235
4.1%
7 MATERNAL EXPOSURE DURING PREGNANCY 1,228
4.0%
8 NAUSEA 1,055
3.5%
9 DIARRHOEA 1,022
3.4%
10 EXPOSURE DURING PREGNANCY 998
3.3%
11 RENAL FAILURE 951
3.1%
12 FATIGUE 904
3.0%
13 ACUTE KIDNEY INJURY 901
3.0%
14 CHRONIC KIDNEY DISEASE 897
2.9%
15 DEPRESSION 867
2.8%
16 OSTEOPOROSIS 863
2.8%
17 ABORTION SPONTANEOUS 847
2.8%
18 PYREXIA 843
2.8%
19 ANAEMIA 826
2.7%
20 VIROLOGIC FAILURE 804
2.6%
21 PREMATURE BABY 795
2.6%
22 VOMITING 773
2.5%
23 RENAL IMPAIRMENT 719
2.4%
24 DEATH 711
2.3%
25 OFF LABEL USE 700
2.3%
26 DRUG RESISTANCE 650
2.1%
27 ASTHENIA 602
2.0%
28 DRUG INEFFECTIVE 598
2.0%
29 RASH 585
1.9%
30 BONE DENSITY DECREASED 572
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.